Download Docs
Export

RYAMRA

50198265 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 3, 2026
Serial No. 50198265
Examining Attorney null
Class Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, central nervous system diseases and disorders, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, and epilepsy; Pharmaceutical preparations for the treatment and prevention of metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, cancers, cerebrovascular diseases, vitiligo, alopecia areata, psoriatic arthritis, neurodevelopmental disorders, cystic fibrosis, narcolepsy, ADHD, and autism spectrum disorder; 005; 006; 018; 044; 046; 051; 052
RYAMRA
Case Type Trademark
Status New application awaiting assignment to an examining attorney. <a href="https://www.uspto.gov/dashboard/trademarks/application-timeline.html">See current trademark processing wait times </a> for more information.
Last Updated: 1 day, 23 hours ago
Filing Date # Docket Text
to view the full docket.